Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Q4 EARNINGS: Wright and Tornier deal to close in H1, as both firms see sales growth

This article was originally published in Clinica

Executive Summary

Wright Medical has preliminarily reported 23% sales growth in its fourth fiscal quarter, but has fallen short of analyst expectations. It is expecting Q4 revenues of $83.3m, lower than analyst estimates of $84.4m. The firm did not give figures for net income (or loss), but analysts are predicting an adjusted loss of $0.26 per share in Q4, widening from a loss of $0.17 per share in Q4 2013.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT102276

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel